Abstract
Long chain noncoding RNAs (LncRNAs), a class of noncoding RNA nucleotides longer than 200 bp, have important roles in a variety of biological processes. Accumulating evidence has confirmed the involvement of LncRNAs in cancer initiation, development and progression. We investigated the expression of LncRNA PEG10 in a cohort of esophageal carcinomas to assess its impact on esophageal cancer cell proliferation, apoptosis and invasion. Quantitaive reverse transcription polymerase chain reaction assays were used to quantify LncRNA PEG10 expression levels in 43 paired EC samples and adjacent non-neoplastic tissues. Cell growth, apoptosis and Transwell invasion assays were used to evaluate the effects of LncRNA PEG10 on esophageal cancer cells. LncRNA PEG10 was expressed at higher levels in esophageal cancer tissues than in adjacent non-neoplastic tissues (P<0.05). This relatively high expression was significantly associated with the occurrence of lymph node metastases (P<0.05). Apoptosis and migration rates were significantly decreased in two esophageal cancer cell lines (EC9706 and KYSE150) transfected with si-LncRNA PEG10 (P<0.05). Downregulation of LncRNA PEG10 decreased the expression of PEG10 (P<0.05). Our results indicated that LncRNA PEG10 is upregulated in esophageal cancer tissues, and its downregulation inhibits proliferation and invasion, and promotes apoptosis in esophageal cancer cells. LncRNA PEG10 may serve as a therapeutic agent in esophageal cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Parkin DM, Bray F, Ferlay J, Pisani P . Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74–08.
Holmes RS, Vaughan TL . Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol 2007; 17: 2–9.
Brown LM, Devesa SS, Chow WH . Incidence of adenocarcinoma of the esoph-agus among white Americans by sex, stage, and age. J Natl Cancer Inst 2008; 100: 1184–1187.
Bollschweiler E, Wolfgarten E, Gutschow C, Hölscher AH . Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001; 92: 549–555.
Rinn JL, Chang HY . Genome regulation by long noncoding RNAs. Annu Rev Biochem 2012; 81: 145–166.
Ponting CP, Oliver PL, Reik W . Evolution and functions of long noncoding RNAs. Cell 2009; 136: 629–641.
Nacher JC . Community structure of non-coding RNA interaction network. J Integr Bioinform 2013; 10: 217.
Du Toit A . Non-coding RNA: RNA stability control by Pol II. Nat Rev Mol Cell Biol 2013; 14: 128.
Jin G, Sun J, Isaacs SD, Wiley KE, Kim ST, Chu LW et al. Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk. Carcinogenesis 2011; 32: 1655–1659.
Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464: 1071–1076.
Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, Park IH et al. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet 2010; 42: 1113–1117.
Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y et al. CREB upregulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res 2010; 38: 5366–5383.
Khaitan D, Dinger ME, Mazar J, Crawford J, Smith MA, Mattick JS et al. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res 2011; 71: 3852–3862.
Yang F, Zhang L, Huo XS, Yuan JH, Xu D, Yuan SX et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 2011; 54: 1679–1689.
Cui Z, Ren S, Lu J, Wang F, Xu W, Sun Y et al. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor. Urol Oncol 2013; 31: 1117–1123.
Wang Y, Chen W, Yang C, Wu W, Wu S, Qin X et al. Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer. Int J Oncol 2012; 41: 276–284 14.
Wilusz JE, Sunwoo H, Spector DL . Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 2009; 23: 1494–1504.
Ono R, Kobayashi S, Wagatsuma H, Aisaka K, Kohda T, Kaneko-Ishino T et al. A retrotransposonderived gene, PEG10, is a novel imprinted gene located on human chromosome 7q21. Genomics 2001; 73: 232–237.
Clark MB, Janicke M, Gottesbuhren U, Kleffmann T, Legge M, Poole ES et al. Mammalian genePEG10 expresses two reading frames by high efficiency -1frameshifting in embryonic-associated tissues. J Biol Chem 2007; 282: 37359–37369.
O'Doherty AM, O'Shea LC, Fair T . Bovine DNA methylation imprints are established in an oocyte size-specific manner, which are coordinated with the expression of the DNMT3 family proteins. Biol Reprod 2012; 86: 67.
Jia HL, Ye QH, Qin LX, Budhu A, Forgues M, Chen Y et al. Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma. Clin Cancer Res 2007; 13: 1133–1139.
Ip WK, Lai PB, Wong NL, Sy SM, Beheshti B, Squire JA et al. Identification of PEG10 as a progression related biomarker for hepatocellular carcinoma. Cancer Lett 2007; 250: 284–291.
Liu Z, Yang Z, Liu D, Li D, Zou Q, Yuan Y et al. TSG101 and PEG10 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder. Oncol Lett 2014; 7: 1128–1138.
Deng X, Hu Y, Ding Q, Han R, Guo Q, Qin J et al. PEG10 plays a crucial role in human lung cancer proliferation, progression, prognosis and metastasis. Oncol Rep 2014; 32: 2159–2167.
Saad Y, El-Serafy M, Eldin MS, Abdellatif Z, Khatab H, Elbaz T et al. New genetic markers for diagnosis of hepatitis C related hepatocellular carcinoma in Egyptian patients. J Gastrointestin Liver Dis 2013; 22: 419–425.
Henke C, Ruebner M, Faschingbauer F, Stolt CC, Schaefer N, Lang N et al. Regulation of murine placentogenesis by the retroviral genes Syncytin-A, Syncytin-B and Peg10. Differentiation 2013; 85: 150–160.
Xiong J, Qin J, Zheng Y, Peng X, Luo Y, Meng X . PEG10 promotes the migration of human Burkitt's lymphoma cells by up-regulating the expression of matrix metalloproteinase-2 and -9. Clin Invest Med 2012; 35: E117–E125.
Chen H, Sun M, Zhao G, Liu J, Gao W, Si S et al. Elevated expression of PEG10 in human placentas from preeclamptic pregnancies. Acta Histochem 2012; 114: 589–593.
Huang W, Long N, Khatib H . Genome-wide identification and initial characterization of bovine long non-coding RNAs from EST data. Anim Genet 2012; 43: 674–682.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Zang, W., Wang, T., Huang, J. et al. Long noncoding RNA PEG10 regulates proliferation and invasion of esophageal cancer cells. Cancer Gene Ther 22, 138–144 (2015). https://doi.org/10.1038/cgt.2014.77
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cgt.2014.77
This article is cited by
-
Transcriptional regulator CTR9 promotes hepatocellular carcinoma progression and metastasis via increasing PEG10 transcriptional activity
Acta Pharmacologica Sinica (2022)
-
Long noncoding RNA BSN-AS2 induced by E2F1 promotes spinal osteosarcoma progression by targeting miR-654-3p/SYTL2 axis
Cancer Cell International (2020)
-
Long non-coding RNAs: crucial regulators of gastrointestinal cancer cell proliferation
Cell Death Discovery (2018)
-
Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis
Molecular Cancer (2016)
-
Upregulation of MALAT-1 and its association with survival rate and the effect on cell cycle and migration in patients with esophageal squamous cell carcinoma
Tumor Biology (2016)